CIBRA Capital Ltd

Position in FOLD — AMICUS THERAPEUTICS, INC.

CIK 2060725 LONDON, X0

Position in FOLD

as of Mar 31, 2026 · filed Apr 24, 2026 Compact

Position Value

$24,403,578

+$21,401,786 QoQ

Shares Held

1,687,661

+700.6% QoQ

Ownership

0.537%

of shares outstanding

% of Portfolio

11.90%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

CIBRA Capital Ltd holds $44,574,686 across 4 Biotechnology names. FOLD ranks #1 (54.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC. This page	1,687,661	$24,403,578
2	ACLX	Arcellx, Inc.	88,623	$10,175,692
3	TERN	Terns Pharmaceuticals, Inc.	151,440	$7,983,916
4	APLS	Apellis Pharmaceuticals, Inc.	50,000	$2,011,500

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$24,403,578	1,687,661	+700.6%	Shares	Sole	2026-04-24
2025-12-31	$3,001,792	210,800	—	Shares	Sole	2026-01-14
No filing history on record for this holder in this stock.